Cargando…

AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis

Renal cell carcinoma (RCC) is a serious threat to people's health due to its rapid progression, and patients easily develop resistance to targeted therapy. The absent in melanoma 2 (AIM2) is a receptor protein that has recently been proposed to play an important role in various diseases. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qi, Gao, Su, Shou, Yi, Jia, Yujie, Wei, Zhihao, Liu, Yuenan, Shi, Jian, Miao, Daojia, Miao, Qi, Zhao, Chuanyi, Liu, Chenchen, Yang, Hongmei, Xu, Tianbo, Zhang, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008700/ https://www.ncbi.nlm.nih.gov/pubmed/36923928 http://dx.doi.org/10.7150/ijbs.79853

Ejemplares similares

circPTPN12 promotes the progression and sunitinib resistance of renal cancer via hnRNPM/IL-6/STAT3 pathway
por: Shou, Yi, et al.
Publicado: (2023)

ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers
por: Yang, Yufei, et al.
Publicado: (2022)

N6‐methyladenosine‐modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis‐regulated Hippo pathway
por: Miao, Daojia, et al.
Publicado: (2023)

Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma
por: Tan, Diaoyi, et al.
Publicado: (2023)

A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
por: Gao, Su, et al.
Publicado: (2021)

Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2020)

LINC00160 mediates sunitinib resistance in renal cell carcinoma via SAA1 that is implicated in STAT3 activation and compound transportation
por: Cheng, Gong, et al.
Publicado: (2020)

ACSL4 suppresses glioma cells proliferation via activating ferroptosis
por: Cheng, Jing, et al.
Publicado: (2020)

ACSL4 is essential for radiation-induced intestinal injury by initiating ferroptosis
por: Ji, Qian, et al.
Publicado: (2022)

Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1
por: Miao, Zong, et al.
Publicado: (2022)

Inhibiting ACSL1-Related Ferroptosis Restrains Murine Coronavirus Infection
por: Xia, Huawei, et al.
Publicado: (2021)

ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumor immunity
por: Gan, Boyi
Publicado: (2022)

ACSL4 contributes to ferroptosis‐mediated rhabdomyolysis in exertional heat stroke
por: He, Sixiao, et al.
Publicado: (2022)

ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression
por: Grube, Julia, et al.
Publicado: (2022)

Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion
por: Tuo, Qing-zhang, et al.
Publicado: (2022)

ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury
por: Wang, Yue, et al.
Publicado: (2022)

Relationship Between ACSL4-Mediated Ferroptosis and Chronic Obstructive Pulmonary Disease
por: Wang, Yingxi, et al.
Publicado: (2023)

Vitamin D Attenuates Ulcerative Colitis by Inhibiting ACSL4-Mediated Ferroptosis
por: Gao, Shuo, et al.
Publicado: (2023)

lncRNA ZFAS1 Positively Facilitates Endothelial Ferroptosis via miR-7-5p/ACSL4 Axis in Diabetic Retinopathy
por: Liu, Yu, et al.
Publicado: (2022)

Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism
por: Ding, Kaiyue, et al.
Publicado: (2023)

RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis
por: Wang, Mu-En, et al.
Publicado: (2023)

Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion
por: Li, Yang, et al.
Publicado: (2019)

Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma
por: Xu, Jiaju, et al.
Publicado: (2021)

The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling
por: Shi, Jian, et al.
Publicado: (2023)

Apatinib Promotes Ferroptosis in Colorectal Cancer Cells by Targeting ELOVL6/ACSL4 Signaling
por: Tian, Xiangyang, et al.
Publicado: (2021)

Baicalin Prevents Myocardial Ischemia/Reperfusion Injury Through Inhibiting ACSL4 Mediated Ferroptosis
por: Fan, Zhenyu, et al.
Publicado: (2021)

Identification of ACSL4 as a biomarker and contributor of ferroptosis in clear cell renal cell carcinoma
por: Guo, Na
Publicado: (2022)

PKCβII–ACSL4 pathway mediating ferroptosis execution and anti‐tumor immunity
por: Lei, Guang, et al.
Publicado: (2022)

Integrative analysis links ferroptosis to necrotizing enterocolitis and reveals the role of ACSL4 in immune disorders
por: Dang, Dan, et al.
Publicado: (2022)

ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries
por: Jia, Bowen, et al.
Publicado: (2023)

Mitochondrial Reactive Oxygen Species Formation Determines ACSL4/LPCAT2-Mediated Ferroptosis
por: Merkel, Melanie, et al.
Publicado: (2023)

YAP/ACSL4 Pathway-Mediated Ferroptosis Promotes Renal Fibrosis in the Presence of Kidney Stones
por: Li, Lei, et al.
Publicado: (2023)

ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma
por: Klasson, Timothy D., et al.
Publicado: (2022)

Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4‐mediated Ferroptosis in Colorectal Cancer
por: Zeng, Kaixuan, et al.
Publicado: (2023)

ACSL4 inhibition prevents macrophage ferroptosis and alleviates fibrosis in bleomycin-induced systemic sclerosis model
por: Cao, Dianyu, et al.
Publicado: (2023)

Novel aspect of neprilysin in kidney fibrosis via ACSL4‐mediated ferroptosis of tubular epithelial cells
por: Lai, Weijing, et al.
Publicado: (2023)

FTO Sensitizes Oral Squamous Cell Carcinoma to Ferroptosis via Suppressing ACSL3 and GPX4
por: Wang, Ziyi, et al.
Publicado: (2023)

microRNA-130b-3p Attenuates Septic Cardiomyopathy by Regulating the AMPK/mTOR Signaling Pathways and Directly Targeting ACSL4 against Ferroptosis
por: Qi, Zhen, et al.
Publicado: (2023)

TIMP1 Indicates Poor Prognosis of Renal Cell Carcinoma and Accelerates Tumorigenesis via EMT Signaling Pathway
por: Shou, Yi, et al.
Publicado: (2022)

CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway
por: Wang, Qi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8a77j011f6khm2jfju8s5cn14l